Based on the above, we investigated the role of simvastatin in cancer cell growth inhibition showing the capacity of this drug to induce apoptosis and demonstrate that the induction of this process implicate the transcription up-regulation of Bax and down-regulation of BCL-2, two genes with important roles in the determination of programmed cell death. This evidence concerns the gene BCL2 and cancer.